Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors
Clinical trial NCT05642949 · UNKNOWN
Trial details
- NCT number
- NCT05642949
- Sponsor
- Minghui Pharmaceutical Pty Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2025-12-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.